PTC Therapeutics Inc. sell The Goldman Sachs Group, Inc.
Start price
18.09.23
/
50%
€22.80
Target price
18.09.24
€20.61
Performance (%)
35.09%
Price
02.05.24
€31.00
Summary
This prediction is currently active. The SELL prediction by The_Goldman_Sachs_Gr for PTC Therapeutics Inc. is trending in the completely wrong direction and now has a performance of 35.09%. This prediction currently runs until 18.09.24. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| PTC Therapeutics Inc. | 29.565% | 29.565% |
| iShares Core DAX® | 0.000% | -2.064% |
| iShares Nasdaq 100 | 0.626% | -2.884% |
| iShares Nikkei 225® | 1.568% | -5.892% |
| iShares S&P 500 | 0.334% | -2.281% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $35.00 to $22.00. They now have a "sell" rating on the stock.
Ratings data for PTCT provided by MarketBeat